Evogene Stock Forecast - 4 Period Moving Average

EVGN Stock  USD 1.69  0.00  0.00%   
The 4 Period Moving Average forecasted value of Evogene on the next trading day is expected to be 1.67 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.59. Evogene Stock Forecast is based on your current time horizon. Although Evogene's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Evogene's systematic risk associated with finding meaningful patterns of Evogene fundamentals over time.
  
At this time, Evogene's Inventory Turnover is very stable compared to the past year. As of the 28th of November 2024, Receivables Turnover is likely to grow to 16.59, while Payables Turnover is likely to drop 0.90. . As of the 28th of November 2024, Common Stock Shares Outstanding is likely to drop to about 4.3 M. In addition to that, Net Loss is likely to drop to about (25.2 M).
A four-period moving average forecast model for Evogene is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Evogene 4 Period Moving Average Price Forecast For the 29th of November

Given 90 days horizon, the 4 Period Moving Average forecasted value of Evogene on the next trading day is expected to be 1.67 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.03, and the sum of the absolute errors of 7.59.
Please note that although there have been many attempts to predict Evogene Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Evogene's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Evogene Stock Forecast Pattern

Backtest EvogeneEvogene Price PredictionBuy or Sell Advice 

Evogene Forecasted Value

In the context of forecasting Evogene's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Evogene's downside and upside margins for the forecasting period are 0.02 and 6.94, respectively. We have considered Evogene's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.69
1.67
Expected Value
6.94
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Evogene stock data series using in forecasting. Note that when a statistical model is used to represent Evogene stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria109.0475
BiasArithmetic mean of the errors 0.0572
MADMean absolute deviation0.1308
MAPEMean absolute percentage error0.0559
SAESum of the absolute errors7.5853
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Evogene. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Evogene and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Evogene

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evogene. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.081.616.81
Details
Intrinsic
Valuation
LowRealHigh
0.112.177.37
Details
2 Analysts
Consensus
LowTargetHigh
3.293.624.02
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evogene. Your research has to be compared to or analyzed against Evogene's peers to derive any actionable benefits. When done correctly, Evogene's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evogene.

Other Forecasting Options for Evogene

For every potential investor in Evogene, whether a beginner or expert, Evogene's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Evogene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Evogene. Basic forecasting techniques help filter out the noise by identifying Evogene's price trends.

View Evogene Related Equities

 Risk & Return  Correlation

Evogene Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Evogene's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Evogene's current price.

Evogene Market Strength Events

Market strength indicators help investors to evaluate how Evogene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evogene shares will generate the highest return on investment. By undertsting and applying Evogene stock market strength indicators, traders can identify Evogene entry and exit signals to maximize returns.

Evogene Risk Indicators

The analysis of Evogene's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Evogene's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting evogene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Evogene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evogene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will appreciate offsetting losses from the drop in the long position's value.

Moving together with Evogene Stock

  0.76FDMT 4D Molecular TherapeuticsPairCorr
  0.8JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.87MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr

Moving against Evogene Stock

  0.85BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.78NAMS NewAmsterdam PharmaPairCorr
  0.6PHVS Pharvaris BVPairCorr
  0.52PMVP Pmv PharmaceuticalsPairCorr
  0.39ESLAW Estrella ImmunopharmaPairCorr
The ability to find closely correlated positions to Evogene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evogene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evogene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evogene to buy it.
The correlation of Evogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evogene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Historical Fundamental Analysis of Evogene to cross-verify your projections.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.46)
Revenue Per Share
1.881
Quarterly Revenue Growth
0.398
Return On Assets
(0.28)
Return On Equity
(0.82)
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.